Welcome to the New England QIN-QIO Webinar!

Transcription

1 Welcome to the New England QIN-QIO Webinar! Thank you for joining. Our presentation will begin shortly. If you haven t already, please dial in to the audio line: Passcode: Slides may be downloaded at:

2 An overview of the AHA initiative to help physicians and patients control cholesterol.

3 Initiative Overview High Cholesterol is a major risk factor for cardiovascular disease and stroke, the No. 1 and No. 5 killers in the U.S. This initiative aims to improve awareness, detection and management of high cholesterol by educating and empowering consumers, healthcare professionals and patients with evidence-based information and tools, while also improving quality of care for patients through AHA s quality improvement program.

4 AHA Goal: Move 9.3 million American adults to cholesterol control by % of Americans have total cholesterol of 200 mg/dl or higher Nearly one of every three American adults has high levels of LDL cholesterol (the bad kind) of Americans have total cholesterol over 240 mg/dl

5 Cholesterol and CVD In 2013, AHA s clinical practice guidelines moved away from treatment to a specific cholesterol level, to treatment based on 10-year risk of having an atherosclerotic cardiovascular disease (ASCVD) or stroke event. This risk is calculated using the evidence-based ASCVD Risk Estimator (provider tool) or the Check. Change. Control. Calculator (patient tool).

6 ASCVD Risk Calculator The ASCVD risk calculator was developed together with the ACC for the 2013 guidelines. The risk calculator assesses risk for having a first time cardiovascular or stroke event in the next 10 years using a specific set of factors: Age Total cholesterol History of diabetes Sex HDL cholesterol Smoking status Race Systolic BP Treatment for BP A risk of 7.5% or greater should prompt providers and patients to discuss further treatment and lifestyle changes.

7 Why Use the ASCVD Risk Calculator? The ASCVD Risk calculator is a starting point for assessing ASCVD risk. We know what medicines work but systems aren t in place to drive control rates. The resulting risk scores provide a baseline to initiate an open discussion with patients and guide decision-making regarding treatment options to prevent ASCVD, including lifestyle changes, risk factor management, and pharmacologic treatment.

8 When to USE the calculator: Patients 40 to 79 years of age without ASCVD Patients with LDL levels 70 to 189 mg/dl without ASCVD and not on statin therapy When NOT to use the calculator: NOT for patients <40 years of age or >79 years of age NOT for patients with established ASCVD or with symptoms suggestive of CVD

9 Patient Calculator Provider Calculator

10

11 National Recognition Criteria Participant Level Register for CCCC Incorporate ASCVD Risk Calculator into practice (attestation) Gold Level Incorporate ASCVD Risk Calculator into practice (attestation) Submit MIPS 438 Cholesterol Management data and achieve control rates of 70 percent or greater within the adult patient populations

12 How Much Data is Required? Registration In order to register, clinics need to provide Your organization s total adult ( 21 years) patient population count The total number of clinical providers in your organization The total number of clinical locations in your health system. Hint: Each location can register individually or as a system overall Your Electronic Health Record (EHR) system Recognition - In 2018, clinics need to provide Participation: Commitment continuously improving use and data capture of ASCVD Risk Estimations into workflows and EHR systems in 2018 Gold: Numerator and denominator data for MIPS Measure #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

13 THERE ARE THREE SUBMISSION CRITERIA FOR MIPS 438 DENOMINATOR (SUBMISSION CRITERIA) 1) Patients aged 21 years at the beginning of the measurement period with clinical ASCVD diagnosis OR 2) Patients aged 21 years at the beginning of the measurement period who have ever had a fasting or direct laboratory result of LDL-C 190 mg/dl or were previously diagnosed with or currently have an active diagnosis of familial or pure hypercholesterolemia OR 3) Patients aged 40 to 75 years at the beginning of the measurement period with Type 1 or Type 2 diabetes and with an LDL-C result of mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period NUMERATOR (SUBMISSION CRITERIA): 1) Patients who are actively using or who receive an order (prescription) for statin therapy at any point during the measurement period

14

15

16 Program Benefits National recognition (annually) Provider tool kit Patient tool kit Part 4 Maintenance of Certification for providers / continuing education Support through AHA field staff Patient and provider ASCVD Risk Calculators

17 Recognition Benefits Listed on CCC Cholesterol website National recognition at AHA Scientific Sessions in 2018 (signage and printed collateral) Certificate can be delivered electronically and displayed within their practice for both Participation and Gold levels Icon badge with AHA proclaimer statement to use internally and externally on webpages and social media Local press release template for clinics Local recognition opportunities

18 Timeline February 5 th Registration & Data Submission Begins Portal remains open for registration only June 1 st Deadline to submit data for recognition Sites will be able to register on a rolling basis after June 1 st ; however recognition data must be submitted by June 1 st.

19 Next Steps Register at Further questions on Check Change Control Cholesterol can be directed to: Cherelle Rozie, Multicultural Initiatives Director, Stefanie Barba, Community Health Director,

20

21 Helpful Resources New England Quality Payment Program (QPP) Support Center Website New England QPP Resources Million Hearts Website: Clinical Quality Measures Crosswalk CMS QPP Website: Merit-Based Incentive Payment Program (MIPS) Quality Measures CMS QPP Website: Alternative Payment Models (APMs) CMS Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO) 2018 Quality Measures sharedsavingsprogram/downloads/2018-reporting-year-narrative-specifications.pdf CMS 2018 Web Interface Measures List Practice%20Resources/2018-Web-Interface_MeasuresList.pdf 21

22 Need Help or Have Questions? Contact Us! Alberta Noonan 22

23 Connect with the New England QIN-QIO on Social Media! This material was prepared by the New England Quality Innovation Network-Quality Improvement Organization (QIN-QIO), the Medicare Quality Improvement Organization for New England, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents presented do not necessarily reflect CMS policy. CMSQINB